Home

Research

Read time: 2 min

Congress highlights

Inflammation and glutamate dysregulation: unravelling the aetiology of schizophrenia

Reduced glutamatergic signalling and immune dysregulation are two major aetiological hypotheses in...

Parkinson's Disease

Read time: 3 min

Congress highlights

New research on Lewy bodies, Pisa syndrome, and changes in the gut

New research showing improved visualization of Lewy bodies, structural brain changes in Pisa...

Alzheimer's Disease

Read time: 3 min

Congress highlights

New perspectives on Alzheimer’s disease

Alzheimer’s disease is not part of normal aging. It is a brain disorder and not all people...

Alzheimer's Disease

Read time: 2 min

Congress highlights

A simple test combination for identifying early Alzheimer’s disease

Many people experience mild cognitive decline, but what is their risk of developing Alzheimer...

Read time: 3 min

Congress highlights

Risk and burden of medication-overuse headache among patients with migraine

What is the risk of medication-overuse headache among patients with migraine, including patients...

Read time: 4 min

Satellite symposium

Early life adversities and mental illness: from vulnerability to treatment response

Exposure to stress, particularly early in life, is a risk factor for a number of psychiatric...

Read time: 2 min

Congress highlights

What happens in the brain during a major depressive episode?

At any one time, 4% of the population is experiencing a major depressive episode,1 said Professor...

Depression, Schizophrenia

Read time: 2 min

Congress highlights

Quarantines, lockdowns, and social isolation: What are we brewing?

The COVID-19 pandemic continues to impact well-being across the globe. Lockdowns, quarantine, and...

Alzheimer's Disease

Read time: 2 min

Satellite symposium

Factors damaging brain health and increasing the risk of Alzheimer’s disease

Knowing the factors that increase the risk of Alzheimer’s disease can help healthcare...

Alzheimer's Disease

Read time: 2 min

Congress highlights

New more accessible and affordable techniques for identifying people at risk of Alzheimer’s disease

In specialist clinics, cerebrospinal fluid biomarkers for Abeta1-42, Abeta1-40, tTau, and pTau or...

Country selection

We are registering that you are located in Brazil - if that's correct then please continue to Progress in Mind Brazil

Not located in Brazil?
Go to a different regional HUB

Continue to Progress in Mind Continue to Progress in Mind Brazil Continue to Progress in Mind MENA Continue to Progress in Mind Spain Continue to Progress in Mind Italy Continue to Progress in Mind Greece Continue to Progress in Mind South East Asia Continue to Progress in Mind Middle East & Africa Continue to Progress in Mind United Kingdom Continue to Progress in Mind Sweden Continue to Progress in Mind Norge Continue to Progress in Mind Denmark Continue to Progress in Mind Finland Continue to Progress in Mind Japan RC Continue to Progress in Mind България Continue to Progress in Mind Israel Continue to Progress in Mind Sweden Continue to Progress in Mind Finland Continue to Progress in Mind Ukraine Continue to Progress in Mind Belgium & Luxembourg Continue to Progress in Mind Switzerland Continue to Progress in Mind Germany Continue to Progress in Mind Austria

You are leaving Progress in Mind

Continue to

Cancel

You are leaving

Progress in Mind Middle East and Africa
HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in Middle East and Africa click here.

Already registered Register

Login as a registered health care professional

Please enter your email to continue

Register as a health care professional

Please enter your email to continue

Hello
Please confirm your email

We have just sent you an email, with a confirmation link.
Before you can gain full access - you need to confirm your email.

The information on this site is exclusively intented for health care professionals.

Accept

Decline